Jun 23, 2022 · 27 min
Business
The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
- 416 episodes
- Updated Thursday
Episodes416
Jun 16, 2022 · 35 min213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback
Jun 9, 2022 · 35 min212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
Jun 2, 2022 · 33 min211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
May 26, 2022 · 34 min210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
May 19, 2022 · 33 minEpisode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
May 12, 2022 · 32 minEpisode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise
May 5, 2022 · 31 minEpisode 207: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner
Apr 28, 2022 · 29 minEpisode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum
Apr 21, 2022 · 32 minEpisode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices
Apr 14, 2022 · 38 minEpisode 204: Leana Wen on the pandemic's new normal and whether Twitter is real life
Apr 7, 2022 · 33 minEpisode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success
Mar 31, 2022 · 29 minIntroducing: Color Code
Mar 24, 2022 · 35 minEpisode 202: Helen Branswell on the pandemic, plus the next FDA debate & the perks of being a CEO
Mar 17, 2022 · 31 minEpisode 201: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas
Mar 10, 2022 · 31 minEpisode 200: Gilead's growing pains, Covid's origins, & Theranos as prestige TV
Mar 3, 2022 · 30 minEpisode 199: Biden's plans for Covid pills, the latest vaccine data, & fighting about CRISPR
Feb 24, 2022 · 30 minEpisode 198: Medical racism, new Covid vaccines, & the resilience of Regeneron
Feb 17, 2022 · 35 minEpisode 197: Robert Califf's FDA return, the future of CRISPR, & another vaccine delay
Feb 10, 2022 · 34 minEpisode 196: Eric Lander's resignation, FDA's about-face, & Pfizer's lucrative pandemic